Bone Morphogenetic Protein 2: Clinical Trials

1 trial of Bone Morphogenetic Protein 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Bone Morphogenetic Protein 2: new trials by email Literature Review of Bone Morphogenetic Protein 2 trials Research Report on Bone Morphogenetic Protein 2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating InductOs in Diaphyseal Tibia Fractures
InductOs - Tibial Fractures
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer2772003-09-012009-09-07

Conditions studied

Tibial Fractures (1)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

Belgium (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  Romania (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)